BofA analyst Anna Lizzul lowered the firm’s price target on Clorox (CLX) to $112 from $124 and keeps a Neutral rating on the shares. The firm adjusted estimates ahead of earnings from the U.S. consumer staples group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $127 from $132 at RBC Capital
- Clorox price target lowered to $110 from $125 at Wells Fargo
- Clorox price target lowered to $110 from $121 at UBS
- Balanced Risk-Reward on Clorox: Limited Near-Term Upside Despite GOJO-Driven Revenue Boost and ERP-Inflated Growth Comparisons
- Clorox Completes Acquisition of Purell Maker GOJO Industries